Atlas Trials

A Study to Evaluate the Safety and Effectiveness of Magnetic Resonance-Guided Ultrasound Ablation of the Anterior Nucleus of Thalamus for the Treatment of Drug-resistant Epilepsy.

Clinical trial NCT07249190 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07249190
Sponsor
Chinese PLA General Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Epilepsy (Treatment Refractory)
Start date
2025-12-01
Primary completion
2027-11-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.